Susquehanna International Group, LLP Hookipa Pharma Inc. Call Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	BUY	$0.59 - $1.04 $1,416 - $2,496	2,400 Added 3.02%	81,800 $48,000
Q1 2024 May 07, 2024	BUY	$0.61 - $0.83 $48,434 - $65,902	79,400 New	79,400 $56,000
Q3 2022 Nov 14, 2022	SELL	$1.27 - $15.0 $67,564 - $798,000	-53,200 Reduced 62.51%	31,900 $43,000
Q2 2022 Aug 15, 2022	BUY	$1.33 - $2.31 $4,123 - $7,161	3,100 Added 3.78%	85,100 $139,000
Q1 2022 May 16, 2022	BUY	$1.26 - $2.52 $51,030 - $102,060	40,500 Added 97.59%	82,000 $187,000
Q3 2021 Nov 15, 2021	BUY	$5.89 - $9.35 $244,435 - $388,025	41,500 New	41,500 $244,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.